DE112004002914A5 - Verbindungen und Verfahren zur Immunsuppression - Google Patents

Verbindungen und Verfahren zur Immunsuppression Download PDF

Info

Publication number
DE112004002914A5
DE112004002914A5 DE112004002914T DE112004002914T DE112004002914A5 DE 112004002914 A5 DE112004002914 A5 DE 112004002914A5 DE 112004002914 T DE112004002914 T DE 112004002914T DE 112004002914 T DE112004002914 T DE 112004002914T DE 112004002914 A5 DE112004002914 A5 DE 112004002914A5
Authority
DE
Germany
Prior art keywords
immunosuppression
compounds
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE112004002914T
Other languages
English (en)
Inventor
Rainer Blasczyk
Constanca Sofia Ferreira De Figueiredo
Axel Seltsam
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medizinische Hochschule Hannover
Original Assignee
Medizinische Hochschule Hannover
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medizinische Hochschule Hannover filed Critical Medizinische Hochschule Hannover
Publication of DE112004002914A5 publication Critical patent/DE112004002914A5/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1138—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against receptors or cell surface proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C12N2310/111—Antisense spanning the whole gene, or a large part of it
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering N.A.
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/50—Physical structure
    • C12N2310/53—Physical structure partially self-complementary or closed
DE112004002914T 2004-05-06 2004-05-06 Verbindungen und Verfahren zur Immunsuppression Withdrawn DE112004002914A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/DE2004/000956 WO2005108572A1 (de) 2004-05-06 2004-05-06 Verbindungen und verfahren zur immunsuppression

Publications (1)

Publication Number Publication Date
DE112004002914A5 true DE112004002914A5 (de) 2007-05-24

Family

ID=34957771

Family Applications (1)

Application Number Title Priority Date Filing Date
DE112004002914T Withdrawn DE112004002914A5 (de) 2004-05-06 2004-05-06 Verbindungen und Verfahren zur Immunsuppression

Country Status (2)

Country Link
DE (1) DE112004002914A5 (de)
WO (1) WO2005108572A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8236771B2 (en) 2004-05-18 2012-08-07 National Institute Of Transplantation Foundation Vectors and methods for long-term immune evasion to prolong transplant viability
EP1963508A2 (de) * 2005-11-30 2008-09-03 Intradigm Corporation Zusammensetzungen und verfahren zur verwendung von sirna zum knockdown der genexpression und zur verbesserung der transplantation solider organe und von zellen
EP3406139A1 (de) 2017-05-26 2018-11-28 Medizinische Hochschule Hannover Procédé de modification génétique d'un tissu vascularisé
EP3441461A1 (de) * 2017-08-11 2019-02-13 Baylor College of Medicine Cd1d-restringierte nkt-zellen als plattform für gebrauchsfertige krebsimmuntherapie
EP4139458A1 (de) * 2020-04-23 2023-03-01 AZTherapies, Inc. Zelluläre ablation von hla-klasse-i-mhc

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2110946A1 (en) * 1992-12-09 1994-06-10 Elazar Rabbani Induction of immunocompatibility by nucleic acid
JPH09503655A (ja) * 1993-09-03 1997-04-15 チロン ビアジーン インコーポレイティド 自己免疫応答の抑制方法
US20030084471A1 (en) * 2000-03-16 2003-05-01 David Beach Methods and compositions for RNA interference
AU2003207708A1 (en) * 2002-02-20 2003-09-09 Sirna Therapeutics, Inc. Rna interference mediated inhibition of map kinase genes
CA2388441A1 (en) * 2002-06-10 2003-12-10 Wei-Ping Min Immunomodulation using rna interference
GB0307206D0 (en) * 2003-03-28 2003-04-30 Axordia Ltd Hyperproliferation

Also Published As

Publication number Publication date
WO2005108572A1 (de) 2005-11-17

Similar Documents

Publication Publication Date Title
ATE486859T1 (de) Verbindungen modulierende thrombopoietinaktivität und verfahren
DE602006021341D1 (de) Rauchgasnassentschwefelungsvorrichtung und verfahren zur rauchgasnassentschwefelung
DE602006021318D1 (de) Insektizidzusammensetzungen und verfahren zur hersn
ATE492120T1 (de) Verfahren und vorrichtungen zur dienstakquisition
DE602006007458D1 (de) Verfahren und vorrichtung zur bohrlochfluidanalyse
DE602005014371D1 (de) Einrichtung und verfahren zur unabhängigen positionierung
DE502006002714D1 (de) Parkhilfsvorrichtung und verfahren zur parkunterstützung
DE502005004969D1 (de) Verfahren zur fahrerunterstützung
DE602005010977D1 (de) Verfahren und System zur Farbauswahl mittels semantische Farbnamen
DE602005024119D1 (de) Verfahren zum allergennachweis
DE602005003951D1 (de) Verbindungen und verfahren zur inhibierung der mitotischen progression durch hemmung von aurorakinase
ATE460403T1 (de) Verbindungen und verfahren zur modulierung von fx-rezeptoren
DE502005010287D1 (de) Verfahren zur hydrocyanierung
DE602005012489D1 (de) Verfahren zur Abwasserbehandlung
DE602006020089D1 (de) Verfahren zur CVI
DE602005000993D1 (de) Verfahren und Modul zur Netzwerkanalyse
DE502005000111D1 (de) Verfahren zur kontinuierlichen Hydrosilylierung
DE602006001222D1 (de) System und Verfahren zur Patientenpositionierung
DE602006000614D1 (de) Vorrichtung und Verfahren zur Standortbestimmung
DE602006007648D1 (de) Verfahren zur implementierung der zugriffsbereichs
DE602005023261D1 (de) Duale Speichervorrichtung und Verfahren dergleichen
ATE394369T1 (de) Verfahren zur aufreinigung von mesotrion
ATE552250T1 (de) Verfahren zur herstellung von duloxetin und verwandten verbindungen
DE602006010725D1 (de) Verfahren und einrichtung zur 3d-bildgebung
DE602006004185D1 (de) Verfahren zur herstellung geschützter amidine

Legal Events

Date Code Title Description
8139 Disposal/non-payment of the annual fee